Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.44 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.44 |
| ▸ | CA2 | P00918 | 8/20 | 0.40 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.40 |
| ▸ | CA1 | P00915 | 6/20 | 0.39 |
| ▸ | SLC15A1 | P46059 | 1/20 | 0.37 |
| ▸ | FDPS | P14324 | 1/20 | 0.37 |
| ▸ | GPR84 | Q9NQS5 | 4/20 | 0.36 |
| ▸ | ACE2 | Q9BYF1 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1786228 | 0.86 | ALDH1A1 (0.48) | ALDH1A1TDP1CA1FDPSGPR84 | |
| SCHEMBL22500721 | 0.82 | GPR84 (0.50) | ALDH1A1TDP1CA2MAPK1GPR84 | |
| SCHEMBL13863445 | 0.81 | TDP1 (0.39) | ALDH1A1TDP1 | |
| Bicarbonate SCHEMBL6442737 | 0.80 | CA2 (0.52) | TDP1CA2MAPK1CA1SLC15A1 | |
| SCHEMBL7943803 | 0.80 | ALDH1A1 (0.44) | ALDH1A1CA2MAPK1CA1SLC15A1 | |
| SCHEMBL1369967 | 0.79 | ALDH1A1 (0.46) | ALDH1A1TDP1CA2MAPK1CA1 | |
| SCHEMBL22345156 | 0.77 | DNM1 (0.47) | ALDH1A1TDP1CA2MAPK1CA1 | |
| SCHEMBL3185161 | 0.77 | DNM1 (0.47) | ALDH1A1TDP1CA2MAPK1CA1 | |
| SCHEMBL13863440 | 0.77 | ALDH1A1 (0.39) | ALDH1A1TDP1 | |
| SCHEMBL28752342 | 0.76 | CA2 (0.47) | ALDH1A1TDP1CA2MAPK1CA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8632792-B2 | Cooling sensation agent composition and sensory stimulation agent composition | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2014-01-21 | — | — | US | disclosed |
| US-20110117147-A1 | COOLING SENSATION AGENT COMPOSITION AND SENSORY STIMULATION AGENT COMPOSITION | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2011-05-19 | — | — | US | disclosed |
| WO-2009123355-A2 | COOLING SENSATION AGENT COMPOSITION AND SENSORY STIMULATION AGENT COMPOSITION | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2009-10-08 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110117147-A1 | COOLING SENSATION AGENT COMPOSITION AND SENSORY STIMULATION AGENT COMPOSITION | TRPA1, HRH1, HRH2 | ALDH1A1 520/4885TDP1 3995/4885CA2 3566/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.